Hummingbird Bioscience
Hummingbird Bioscience has 1 licensing announcement in this dataset, dated 2025-01-07.
- Country / operating region
- Singapore
- Ticker
- 查無
- Headquarters
- 查無
- Founded
- 查無
- Business
- Antibody and ADC research and development
- Website
- hummingbirdbioscience.com
Pipeline / products
| Asset / platform | Target | Modality | Stage at announcement | Announcement date |
|---|---|---|---|---|
| monoclonal antibodies against an undisclosed target | 查無 | 查無 | 查無 | 2025-01-07 |
Licensing deals
| Date | Counterparty | Asset / platform | Upfront | Near-term | Milestones | Potential total | Other disclosed terms |
|---|---|---|---|---|---|---|---|
| 2025-01-07 | Immunome | monoclonal antibodies against an undisclosed target | 查無 | 查無 | 查無 | 查無 | — |
| Counterparty | Territory | Royalties |
|---|---|---|
| Immunome | Worldwide | Royalties; rates not disclosed. |
Catalysts
查無
Latest monthly revenue
查無
Most advanced drug
查無
Drugnews analysis
查無